{"entity":{"type":"insider","cik":"0001626003","url":"/insider/0001626003","json_url":"/insider/0001626003.json","name":"Cohen Yuval","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":31,"first":"2014-12-04","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Cohen Yuval","source":"filing","n_filings":31,"first_seen":"2014-12-04","last_seen":"2026-08-10"}],"transactions":[{"id":9255247,"accession":"0001193125-26-342485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-342485","line_url":"/filing/0001193125-26-342485#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":10.0821,"price_display":"10.08","price_state":"stated","total_value":171395.7,"total_display":"171,395.70","shares_owned_after":157316.0,"shares_owned_after_display":"157,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-10","scope":"insider"},{"id":5929570,"accession":"0001193125-26-057159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-057159","line_url":"/filing/0001193125-26-057159#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13871.0,"shares_display":"13,871","price_per_share":7.7826,"price_display":"7.78","price_state":"stated","total_value":107952.4446,"total_display":"107,952.44","shares_owned_after":174316.0,"shares_owned_after_display":"174,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":4271164,"accession":"0001193125-25-251639","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-251639","line_url":"/filing/0001193125-25-251639#line-4","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8973.0,"shares_display":"8,973","price_per_share":17.14,"price_display":"17.14","price_state":"stated","total_value":153797.22,"total_display":"153,797.22","shares_owned_after":138187.0,"shares_owned_after_display":"138,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-27","scope":"insider"},{"id":4271151,"accession":"0001193125-25-251639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-251639","line_url":"/filing/0001193125-25-251639#line-2","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18660.0,"shares_display":"18,660","price_per_share":17.01,"price_display":"17.01","price_state":"stated","total_value":317406.6,"total_display":"317,406.60","shares_owned_after":138187.0,"shares_owned_after_display":"138,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-24","filed_date":"2025-10-27","scope":"insider"},{"id":4263306,"accession":"0000950170-25-022512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-022512","line_url":"/filing/0000950170-25-022512#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7134.0,"shares_display":"7,134","price_per_share":8.7559,"price_display":"8.76","price_state":"stated","total_value":62464.5906,"total_display":"62,464.59","shares_owned_after":138187.0,"shares_owned_after_display":"138,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-18","scope":"insider"},{"id":2117085,"accession":"0000950170-24-075071","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-15","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11667.0,"shares_display":"11,667","price_per_share":42.237,"price_display":"42.24","price_state":"stated","total_value":492779.079,"total_display":"492,779.08","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-18","scope":"insider"},{"id":2117084,"accession":"0000950170-24-075071","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-14","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7179.0,"shares_display":"7,179","price_per_share":42.237,"price_display":"42.24","price_state":"stated","total_value":303219.423,"total_display":"303,219.42","shares_owned_after":77221.0,"shares_owned_after_display":"77,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-18","scope":"insider"},{"id":2117083,"accession":"0000950170-24-075071","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-13","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2322.0,"shares_display":"2,322","price_per_share":42.237,"price_display":"42.24","price_state":"stated","total_value":98074.314,"total_display":"98,074.31","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-18","scope":"insider"},{"id":2117081,"accession":"0000950170-24-075071","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-12","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1770.0,"shares_display":"1,770","price_per_share":42.237,"price_display":"42.24","price_state":"stated","total_value":74759.49,"total_display":"74,759.49","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-18","scope":"insider"},{"id":2117075,"accession":"0000950170-24-075071","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-8","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9333.0,"shares_display":"9,333","price_per_share":46.0203,"price_display":"46.02","price_state":"stated","total_value":429507.4599,"total_display":"429,507.46","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-18","scope":"insider"},{"id":2117073,"accession":"0000950170-24-075071","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-7","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1770.0,"shares_display":"1,770","price_per_share":46.0203,"price_display":"46.02","price_state":"stated","total_value":81455.931,"total_display":"81,455.93","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-18","scope":"insider"},{"id":2117066,"accession":"0000950170-24-075071","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-4","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16830.0,"shares_display":"16,830","price_per_share":50.1662,"price_display":"50.17","price_state":"stated","total_value":844297.146,"total_display":"844,297.15","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-18","scope":"insider"},{"id":2117064,"accession":"0000950170-24-075071","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-075071","line_url":"/filing/0000950170-24-075071#line-3","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12487.0,"shares_display":"12,487","price_per_share":50.1662,"price_display":"50.17","price_state":"stated","total_value":626425.3394,"total_display":"626,425.34","shares_owned_after":84400.0,"shares_owned_after_display":"84,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-18","scope":"insider"},{"id":6497289,"accession":"0001209191-22-045358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045358","line_url":"/filing/0001209191-22-045358#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":0.264,"price_display":"0.26","price_state":"stated","total_value":1003.2,"total_display":"1,003.20","shares_owned_after":98230.0,"shares_owned_after_display":"98,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-11","scope":"insider"},{"id":6429674,"accession":"0001209191-22-029030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-029030","line_url":"/filing/0001209191-22-029030#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10500.0,"shares_display":"10,500","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":2625.0,"total_display":"2,625.00","shares_owned_after":94430.0,"shares_owned_after_display":"94,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":6345479,"accession":"0001209191-22-017449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-017449","line_url":"/filing/0001209191-22-017449#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8600.0,"shares_display":"8,600","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":3182.0,"total_display":"3,182.00","shares_owned_after":83930.0,"shares_owned_after_display":"83,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-09","scope":"insider"},{"id":2120031,"accession":"0001209191-20-057851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057851","line_url":"/filing/0001209191-20-057851#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4240.0,"shares_display":"4,240","price_per_share":1.209,"price_display":"1.21","price_state":"stated","total_value":5126.16,"total_display":"5,126.16","shares_owned_after":75330.0,"shares_owned_after_display":"75,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":3088365,"accession":"0001209191-20-019502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-019502","line_url":"/filing/0001209191-20-019502#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4300.0,"shares_display":"4,300","price_per_share":3.49,"price_display":"3.49","price_state":"stated","total_value":15007.0,"total_display":"15,007.00","shares_owned_after":71090.0,"shares_owned_after_display":"71,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-17","scope":"insider"},{"id":8102797,"accession":"0001209191-19-055941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-055941","line_url":"/filing/0001209191-19-055941#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430.0,"shares_display":"1,430","price_per_share":4.26,"price_display":"4.26","price_state":"stated","total_value":6091.8,"total_display":"6,091.80","shares_owned_after":66790.0,"shares_owned_after_display":"66,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-12","scope":"insider"},{"id":7927854,"accession":"0001209191-19-045444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-045444","line_url":"/filing/0001209191-19-045444#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1175.0,"shares_display":"1,175","price_per_share":6.056,"price_display":"6.06","price_state":"stated","total_value":7115.8,"total_display":"7,115.80","shares_owned_after":65360.0,"shares_owned_after_display":"65,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-12","scope":"insider"},{"id":8008737,"accession":"0001209191-19-029514","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-029514","line_url":"/filing/0001209191-19-029514#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":995.0,"shares_display":"995","price_per_share":6.9898,"price_display":"6.99","price_state":"stated","total_value":6954.851,"total_display":"6,954.85","shares_owned_after":64185.0,"shares_owned_after_display":"64,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-14","scope":"insider"},{"id":8754111,"accession":"0001209191-19-019345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-019345","line_url":"/filing/0001209191-19-019345#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1530.0,"shares_display":"1,530","price_per_share":6.49,"price_display":"6.49","price_state":"stated","total_value":9929.7,"total_display":"9,929.70","shares_owned_after":63190.0,"shares_owned_after_display":"63,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-14","scope":"insider"},{"id":6519315,"accession":"0001209191-18-030366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-030366","line_url":"/filing/0001209191-18-030366#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1725.0,"shares_display":"1,725","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":10091.25,"total_display":"10,091.25","shares_owned_after":61660.0,"shares_owned_after_display":"61,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider"},{"id":6099860,"accession":"0001209191-18-019757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-019757","line_url":"/filing/0001209191-18-019757#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1160.0,"shares_display":"1,160","price_per_share":6.885,"price_display":"6.88","price_state":"stated","total_value":7986.6,"total_display":"7,986.60","shares_owned_after":59935.0,"shares_owned_after_display":"59,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-14","filed_date":"2018-03-15","scope":"insider"},{"id":4198419,"accession":"0001209191-17-060145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-060145","line_url":"/filing/0001209191-17-060145#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.1685,"price_display":"7.17","price_state":"stated","total_value":7168.5,"total_display":"7,168.50","shares_owned_after":58775.0,"shares_owned_after_display":"58,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-11-13","scope":"insider"},{"id":4197609,"accession":"0001209191-17-048535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-048535","line_url":"/filing/0001209191-17-048535#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1695.0,"shares_display":"1,695","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":10170.0,"total_display":"10,170.00","shares_owned_after":57775.0,"shares_owned_after_display":"57,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-11","scope":"insider"},{"id":4357679,"accession":"0001209191-17-031700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-031700","line_url":"/filing/0001209191-17-031700#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3250.0,"shares_display":"3,250","price_per_share":6.012,"price_display":"6.01","price_state":"stated","total_value":19539.0,"total_display":"19,539.00","shares_owned_after":56080.0,"shares_owned_after_display":"56,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-12","scope":"insider"},{"id":9270207,"accession":"0001209191-17-004954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-004954","line_url":"/filing/0001209191-17-004954#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1340.0,"shares_display":"1,340","price_per_share":7.64,"price_display":"7.64","price_state":"stated","total_value":10237.6,"total_display":"10,237.60","shares_owned_after":32830.0,"shares_owned_after_display":"32,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2017-01-20","scope":"insider"},{"id":2835412,"accession":"0001209191-16-151867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151867","line_url":"/filing/0001209191-16-151867#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1340.0,"shares_display":"1,340","price_per_share":7.64,"price_display":"7.64","price_state":"stated","total_value":10237.6,"total_display":"10,237.60","shares_owned_after":12830.0,"shares_owned_after_display":"12,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-23","scope":"insider"},{"id":2924871,"accession":"0001209191-16-126119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-126119","line_url":"/filing/0001209191-16-126119#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":3.34,"price_display":"3.34","price_state":"stated","total_value":5010.0,"total_display":"5,010.00","shares_owned_after":11490.0,"shares_owned_after_display":"11,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-07","scope":"insider"},{"id":2054432,"accession":"0001209191-16-121465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-121465","line_url":"/filing/0001209191-16-121465#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2125.0,"shares_display":"2,125","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":5100.0,"total_display":"5,100.00","shares_owned_after":9990.0,"shares_owned_after_display":"9,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider"},{"id":8497606,"accession":"0001209191-15-081889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-081889","line_url":"/filing/0001209191-15-081889#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":535.0,"shares_display":"535","price_per_share":1.7593,"price_display":"1.76","price_state":"stated","total_value":941.2255,"total_display":"941.23","shares_owned_after":6835.0,"shares_owned_after_display":"6,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-24","scope":"insider"},{"id":8904965,"accession":"0001209191-15-080166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-080166","line_url":"/filing/0001209191-15-080166#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":850.0,"shares_display":"850","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":1470.5,"total_display":"1,470.50","shares_owned_after":6300.0,"shares_owned_after_display":"6,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-13","filed_date":"2015-11-16","scope":"insider"},{"id":8094569,"accession":"0001209191-15-067741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-067741","line_url":"/filing/0001209191-15-067741#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550.0,"shares_display":"550","price_per_share":1.9462,"price_display":"1.95","price_state":"stated","total_value":1070.41,"total_display":"1,070.41","shares_owned_after":5450.0,"shares_owned_after_display":"5,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-24","filed_date":"2015-08-25","scope":"insider"},{"id":8786116,"accession":"0001209191-15-066446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-066446","line_url":"/filing/0001209191-15-066446#line-2","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1075.0,"shares_display":"1,075","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":2042.5,"total_display":"2,042.50","shares_owned_after":4900.0,"shares_owned_after_display":"4,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-18","scope":"insider"},{"id":8786115,"accession":"0001209191-15-066446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-066446","line_url":"/filing/0001209191-15-066446#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1025.0,"shares_display":"1,025","price_per_share":1.937,"price_display":"1.94","price_state":"stated","total_value":1985.425,"total_display":"1,985.42","shares_owned_after":3825.0,"shares_owned_after_display":"3,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-18","scope":"insider"},{"id":8577773,"accession":"0001209191-15-053410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-053410","line_url":"/filing/0001209191-15-053410#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":2952.0,"total_display":"2,952.00","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-15","scope":"insider"},{"id":6710136,"accession":"0001209191-14-076516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-076516","line_url":"/filing/0001209191-14-076516#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":1464.0,"total_display":"1,464.00","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-17","filed_date":"2014-12-18","scope":"insider"},{"id":6680525,"accession":"0001209191-14-073176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-073176","line_url":"/filing/0001209191-14-073176#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":1650.0,"total_display":"1,650.00","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-04","filed_date":"2014-12-04","scope":"insider"},{"id":6561523,"accession":"0001209191-14-072930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072930","line_url":"/filing/0001209191-14-072930#line-1","is_derivative":false,"issuer_cik":"0001595097","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001595097","owner_cik":"0001626003","owner_name":"Cohen Yuval","owner_url":"/insider/0001626003","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-04","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":27,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001595097","name":"Corbus Pharmaceuticals Holdings, Inc.","url":"/issuer/0001595097","role":"Director, Officer (Chief Executive Officer)","n_filings":31,"first_seen":"2014-12-04","last_seen":"2026-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001626003","retrieved_at":"2026-08-20T21:29:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}